Navigation Links
GPS for the Prostate: System Keeps Radiation Therapy on Target
Date:2/13/2008

SEATTLE, Feb. 13 /PRNewswire/ -- A system for tracking the movement of the prostate during radiation therapy has gone into service at the Seattle Cancer Care Alliance. Featuring tiny GPS-type positioning transponders implanted inside the prostate, the technology tracks any movement of the prostate in real time and alerts technicians if the organ moves beyond pre-determined parameters so they can adjust the external beam of radiation.

The advantage of using the system is that the radiation dose stays on target and less of it reaches surrounding healthy tissue, which reduces potential side effects. There is also the potential for using higher doses of radiation to attack tumors precisely while reducing the amount of time patients must undergo the procedure, according to Ken Russell, M.D., radiation oncology clinical chief at the SCCA and the University of Washington.

"The purpose of radiation oncology is to accurately deliver the treatment to the cancer and avoid as much as possible the normal nearby organs," said Russell, who is also vice chairman of the UW Department of Radiation Oncology. "The prostate is a moving target."

Calypso Medical Technologies of Seattle manufactures the system, which is called the Calypso 4D Localization System. It consists of five components that work together: electromagnetic transponders the size of a grain of rice, a console the size of a large rolling suitcase, an electromagnetic array to receive the transponder signals, a tracking workstation and infrared cameras installed in the treatment room.

Three transponders are implanted during a 15-minute outpatient procedure at the UW urology clinic. The process is similar to a hollow-needle biopsy. The radiation treatment is done at the SCCA outpatient clinic on the Fred Hutchinson Cancer Research Center campus at South Lake Union.

About Seattle Cancer Care Alliance

Seattle Cancer Care Alliance, established in 1998, unites the adult and pediatric cancer-care services of Fred Hutchinson Cancer Research Center, UW Medicine and Children's Hospital and Regional Medical Center. A major focus of SCCA is to speed the transfer of new diagnostic and treatment techniques from the research setting to the patient bedside while providing premier, patient-focused cancer care. Patients who come to SCCA receive the latest research-based cancer therapies as well as cutting-edge treatments for a number of non-malignant diseases under development by its partner organizations. SCCA has three clinical-care sites: an outpatient clinic on the Fred Hutchinson campus, a pediatric-inpatient unit at Children's and an adult-inpatient unit at UW Medical Center. For more information about SCCA, visit http://www.seattlecca.org.

Media Contact:

Dean Forbes, (206) 667-2896


'/>"/>
SOURCE Seattle Cancer Care Alliance
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Different method of evaluating the urinary tract system reduces radiation dose
2. Lutheran Senior Services Partners with Silverchair Learning Systems to Enhance Employee Training and Education
3. Exempla Healthcare Contracts For Talismans Quality Donor System
4. Heartline(R) Fitness Systems Named to Inc. Magazines Inaugural List of the 5000 Fastest Growing Private Companies in U.S....
5. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology
6. Plexus Systems Ranks in Top Third of the 2007 Inc. 5,000 with Three-Year Sales Growth of 226%
7. Document Security Systems (Amex: DMC) Invites You to a Landmark Event
8. Flu Vaccinations Begin on September 29 Maxim Health Systems to Provide 24,000 Flu Shot Clinics Nationwide
9. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
10. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
11. NAMSA Deploys TrackWise Software as its Quality Management System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... ... will spark a conversation on the current obstacles facing infection prevention and offer ... preventable deaths caused by these infections. , The print component of “Fighting ...
(Date:3/24/2017)... ... March 24, 2017 , ... Texas Physical Therapy Specialists (TexPTS) is pleased ... Huebner Road. The clinic is the group’s 7th location in San Antonio and 23rd ... PT, will provide care from the clinic, which opened March 22, 2017. ...
(Date:3/24/2017)... ... 2017 , ... As the standards bearer of advanced cancer ... positions them as the go-to thought leader in all matters concerning oncology nursing. ... always-on, always-fresh news, views and advocacy engine, called ONS Voice. , The ONS ...
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health ... partnership to prep patients for colonoscopy at the HyGIeaCare® Center that is to ... Miami, FL. , The HyGIeaCare® Prep, cleared by the U.S. Food ...
(Date:3/24/2017)... ... 2017 , ... “Vintage and Harvest A Cultivation of Christian Love” is the ... in North Carolina with his wife, Anna Marie. He and his wife are the ... is also the author of “Shadow and Substance.” , “Love, the agape kind, is ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... 2017  Zymo Research Corp., also known ... Inc., who designs, manufactures and distributes liquid ... teams Zymo Research,s DNA methylation detection and ... products with Hamilton,s high-throughput automation platforms. Zymo ... microbiomics and RNA isolation for use on ...
(Date:3/24/2017)... , March 24, 2017   The ... organization within medical affairs in the pharmaceutical industry ... the chair of a newly formed scientific advisory ... members to form the first ever medical affairs ... For more information about the ACMA, please visit  ...
(Date:3/24/2017)... DUBLIN , Mar. 24, 2017 Research and ... (IPF) Pipeline Analysis, 2016" report to their offering. ... The IPF pipeline is very strong with ... Corporation, Merck & Co., Inc., Biogen and Sanofi are involved in the ... candidates, of which one is in Phase III stage, 15 are in ...
Breaking Medicine Technology: